Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martin-Broto

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
The Lancet. Oncology|December 2, 2019
Risk-based treatment of non-rhabdomyosarcoma soft-tissue sarcoma in childrenJavier Martin-Broto
Current Opinion in Oncology|May 12, 2016
Targeted treatments of sarcomas and connective tumors beside gastrointestinal stromal tumorJavier Martin-Broto, Nadia Hindi
The Oncologist|March 9, 2019
In ReplyJavier Martin-Broto, Nadia Hindi
Current Opinion in Oncology|May 11, 2021
What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?Nadia Hindi, Javier Martin-Broto
Current Opinion in Oncology|June 17, 2020
New drugs in gastrointestinal stromal tumorsJavier Martin-Broto, David S Moura
Future Oncology (London, England)|September 11, 2019
Which goals should we pursue in each line of treatment for advanced soft tissue sarcoma?Javier Martin-Broto, Nadia Hindi, David S Moura
Current Opinion in Oncology|May 10, 2024
Combination treatment with PD1/PDL-1 inhibitors for sarcomas: state of the art, next questionsJavier Martin-Broto, Nadia Hindi, David S Moura
The Lancet. Oncology|March 8, 2019
Pazopanib in the treatment of advanced solitary fibrous tumour - Authors' replyJavier Martin-Broto, David S Moura, Nadia Hindi
Cancers|July 2, 2021
A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New HorizonsJavier Martin-Broto, Jose L Mondaza-Hernandez, David S Moura, et al.
Frontiers in Immunology|March 15, 2021
Sunitinib Exerts <i>In Vitro</i> Immunomodulatory Activity on Sarcomas <i>via</i> Dendritic Cells and Synergizes With PD-1 BlockadeDarina Ocadlikova, Mariangela Lecciso, Javier Martin Broto, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|December 2, 2019
Risk-based treatment of non-rhabdomyosarcoma soft-tissue sarcoma in childrenJavier Martin-Broto
Current Opinion in Oncology|May 12, 2016
Targeted treatments of sarcomas and connective tumors beside gastrointestinal stromal tumorJavier Martin-Broto, Nadia Hindi
The Oncologist|March 9, 2019
In ReplyJavier Martin-Broto, Nadia Hindi
Current Opinion in Oncology|May 11, 2021
What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?Nadia Hindi, Javier Martin-Broto
Current Opinion in Oncology|June 17, 2020
New drugs in gastrointestinal stromal tumorsJavier Martin-Broto, David S Moura
Future Oncology (London, England)|September 11, 2019
Which goals should we pursue in each line of treatment for advanced soft tissue sarcoma?Javier Martin-Broto, Nadia Hindi, David S Moura
Current Opinion in Oncology|May 10, 2024
Combination treatment with PD1/PDL-1 inhibitors for sarcomas: state of the art, next questionsJavier Martin-Broto, Nadia Hindi, David S Moura
The Lancet. Oncology|March 8, 2019
Pazopanib in the treatment of advanced solitary fibrous tumour - Authors' replyJavier Martin-Broto, David S Moura, Nadia Hindi
Cancers|July 2, 2021
A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New HorizonsJavier Martin-Broto, Jose L Mondaza-Hernandez, David S Moura, et al.
Frontiers in Immunology|March 15, 2021
Sunitinib Exerts <i>In Vitro</i> Immunomodulatory Activity on Sarcomas <i>via</i> Dendritic Cells and Synergizes With PD-1 BlockadeDarina Ocadlikova, Mariangela Lecciso, Javier Martin Broto, et al.
Pageof 12